ConductScience.org, home

Paper35732829

The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.

Alaggio R and 82 others. Leukemia, 2022. Cited by 3,367 papers, by iCite.

Cite this record

ConductScience Library. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Papers, record 35732829. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35732829

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.
PubMed
Journal
Leukemia
PubMed
Year
2022
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
3,367
iCite
Relative citation ratio, by iCite
305
iCite
Revised in PubMed
2023-07-19
PubMed

Authors83

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Source PubMed

See all 83 authorsDownload CSV of authors

Topics4

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Hematologic NeoplasmsMajor topic
LymphomaMajor topic
Humans
World Health Organization

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
K08 CA267058NCI NIH HHSUnited StatesK08CA267058PubMed and NIHNIH RePORTER
P30 CA008748NCI NIH HHSUnited StatesP30CA008748PubMed and NIHNIH RePORTER

Download CSV of grants

Trials4

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT06256484A Study to Evaluate the Safety and Preliminary Efficacy of ATA3219 in Participants With Relapsed/Refractory B-cell Non-Hodgkin LymphomaResultsClinicalTrials.gov
NCT07499635Immunophenotypic Evaluation of CD305 and CD85d in B-Cell Lymphoid NeoplasmsBackgroundClinicalTrials.gov
NCT07652580Toxin Exposure and Immune Dysregulation in Non-Hodgkin LymphomaBackgroundClinicalTrials.gov
NCT07678229BRIDGE-NK: Immunotherapy Versus Chemotherapy Induction Followed by Autologous HSCT in Advanced NKTCLResultsClinicalTrials.gov

Download CSV of trials

Comments and corrections3

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Erratum in37468552Correction: "The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms" Leukemia. 2022 Jul;36(7):1720-1748.https://conductscience.org/library/papers/37468552PubMed
Comment in36708220ALK1-negative primary cutaneous anaplastic large cell lymphoma of the hand and wrist.https://conductscience.org/library/papers/36708220PubMed
Comment in36973349Response to the Comments from the Groupe Francophone de Cytogénétique Hématologique (GFCH) on the 5th edition of the World Health Organization classification of haematolymphoid tumors.https://conductscience.org/library/papers/36973349PubMed

Download CSV of comments and corrections

References293

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
18068936A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group.Blood1994https://conductscience.org/library/papers/8068936PubMed
228087540International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease.Blood2017https://conductscience.org/library/papers/28087540PubMed
331352991Castleman Disease.Surg Pathol Clin2019https://conductscience.org/library/papers/31352991PubMed
421487108High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy.Blood2011https://conductscience.org/library/papers/21487108PubMed
517664482Prospective study of rituximab in chemotherapy-dependent human immunodeficiency virus associated multicentric Castleman's disease: ANRS 117 CastlemaB Trial.J Clin Oncol2007https://conductscience.org/library/papers/17664482PubMed
634529020ALL is not the same in the era of genetics.Blood2021https://conductscience.org/library/papers/34529020PubMed
723181981A novel TCF3-HLF fusion transcript in acute lymphoblastic leukemia with a t(17;19)(q22;p13).Cancer Genet2012https://conductscience.org/library/papers/23181981PubMed
826214592Genomics and drug profiling of fatal TCF3-HLF-positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options.Nat Genet2015https://conductscience.org/library/papers/26214592PubMed
928408464Targetable kinase gene fusions in high-risk B-ALL: a study from the Children's Oncology Group.Blood2017https://conductscience.org/library/papers/28408464PubMed
1027870571High Frequency and Poor Outcome of Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia in Adults.J Clin Oncol2017https://conductscience.org/library/papers/27870571PubMed
1128749919Philadelphia chromosome-like acute lymphoblastic leukemia: progress in a new cancer subtype.Clin Adv Hematol Oncol2017https://conductscience.org/library/papers/28749919PubMed
1233054045BCR-ABL1-like acute lymphoblastic leukemia in childhood and targeted therapy.Haematologica2020https://conductscience.org/library/papers/33054045PubMed
1331434701Efficacy of tyrosine kinase inhibitors in Ph-like acute lymphoblastic leukemia harboring ABL-class rearrangements.Blood2019https://conductscience.org/library/papers/31434701PubMed
1427265895Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemia.Nat Commun2016https://conductscience.org/library/papers/27265895PubMed
1527019113Recurrent DUX4 fusions in B cell acute lymphoblastic leukemia of adolescents and young adults.Nat Genet2016https://conductscience.org/library/papers/27019113PubMed
1627824051Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia.Nat Commun2016https://conductscience.org/library/papers/27824051PubMed
1727634205ZNF384-related fusion genes define a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with a characteristic immunotype.Haematologica2017https://conductscience.org/library/papers/27634205PubMed
1830872366NUTM1 is a recurrent fusion gene partner in B-cell precursor acute lymphoblastic leukemia associated with increased expression of genes on chromosome band 10p12.31-12.2.Haematologica2019https://conductscience.org/library/papers/30872366PubMed
1930282799IG-MYC + neoplasms with precursor B-cell phenotype are molecularly distinct from Burkitt lymphomas.Blood2018https://conductscience.org/library/papers/30282799PubMed
2030643249PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia.Nat Genet2019https://conductscience.org/library/papers/30643249PubMed

See all 293 referencesDownload CSV of references

Cited by2,348

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3,367 citations.

PMIDTitleJournalYearIn PapersSource
42985352Hematologic Malignancies Survival Patterns in Elderly Patients: Disparities in Martinique, a Caribbean Population-Based Registry Study, 2008-2021.Clin Epidemiol2026https://conductscience.org/library/papers/42985352PubMed
42979429Hematologic breast malignancies: a single-institution cohort study of 24 patients diagnosed between January 2008 and June 2023, with clinicopathological and outcome analysis.Front Oncol2026https://conductscience.org/library/papers/42979429PubMed
42974429Secondary intraocular extranodal natural killer/T-cell lymphoma with optic nerve involvement: a case report.Front Oncol2026https://conductscience.org/library/papers/42974429PubMed
42967967Posttransplant lymphoproliferative disorders following hematopoietic stem cell transplantation: a clinicopathological study of a large single-center cohort.Ann Hematol2026https://conductscience.org/library/papers/42967967PubMed
42967949A multi-center, single-arm, phase 2 trial of dasatinib in T follicular helper cell lymphomas.Nat Commun2026https://conductscience.org/library/papers/42967949PubMed
42967050Jejunal B-Cell Non-Hodgkin Lymphoma Presenting with a Long Stenosing Lesion in an Adolescent: A Case Report.Cancer Manag Res2026https://conductscience.org/library/papers/42967050PubMed
42960382Colonic Mucosa-Associated Lymphoid Tissue Following Prior Hodgkin Lymphoma: A Diagnostic Challenge and Therapeutic Approach - A Case Report.GE Port J Gastroenterol2026https://conductscience.org/library/papers/42960382PubMed
42959668Aberrant Cluster of Differentiation (CD) Marker Expression Across B-cell Chronic Lymphoproliferative Disorder Subtypes: A Single-Center Flow Cytometry Study From Sri Lanka.Cureus2026https://conductscience.org/library/papers/42959668PubMed
42959663Immune Background Profiles Across B-cell Lymphoproliferative Disorders.Cureus2026https://conductscience.org/library/papers/42959663PubMed
42959460Calcineurin Inhibitor-Free, mTOR-Based Immunosuppression in Chimeric Antigen Receptor T-Cell Therapy for Post-Transplant Lymphoproliferative Disorder.EJHaem2026https://conductscience.org/library/papers/42959460PubMed
42959303Nodal T Follicular Helper Cell Lymphoma With Epstein-Barr Virus-Positive Neoplastic T Cells Derived From Clonal Hematopoiesis.EJHaem2026https://conductscience.org/library/papers/42959303PubMed
42948798Vitality as a Prognostic Biomarker in Hematologic Malignancies: Association With Overall Survival and Progression-Free Survival.Cureus2026https://conductscience.org/library/papers/42948798PubMed
42947919Sintilimab plus R-CHOP versus DA-EPOCH-R as first-line therapy for primary mediastinal large B-cell lymphoma: a real-world comparative cohort study.Front Immunol2026https://conductscience.org/library/papers/42947919PubMed
42943337Obinutuzumab and Chemotherapy for Front-Line Treatment of Follicular Lymphoma Grade 3B and Composite Follicular Lymphoma: A Study of the Croatian Cooperative Group for Hematologic Diseases (KroHem).Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42943337PubMed
42942121Copy-Number Alterations and Copy-Neutral Loss of Heterozygosity in Adult T-ALL: A Descriptive Study in Relation to Day +70 MRD.Int J Mol Sci2026https://conductscience.org/library/papers/42942121PubMed
42940088Richter Transformation of Chronic Lymphocytic Leukaemia: Biology, Diagnosis, and an Evolving Therapeutic Landscape.Biomedicines2026https://conductscience.org/library/papers/42940088PubMed
42939957Plasma IgG N-Glycosylation as a Novel Biomarker of Disease Severity and Prognosis in Diffuse Large B-Cell Lymphoma, Not Otherwise Specified.Biomedicines2026https://conductscience.org/library/papers/42939957PubMed
42938940Conserved Regulatory DNA Methylation in Human and MYC/PI3K-Driven Murine EBV-Negative Burkitt Lymphoma.Cancers (Basel)2026https://conductscience.org/library/papers/42938940PubMed
42938932Targeting Peripheral T-Cell Lymphomas with Chimeric Antigen Receptor Therapy: Mechanistic Challenges, Clinical Landscape and Future Engineering Perspectives.Cancers (Basel)2026https://conductscience.org/library/papers/42938932PubMed
42938799Vitreoretinal Lymphoma: From Pathobiology to Integrated Diagnosis.Cancers (Basel)2026https://conductscience.org/library/papers/42938799PubMed

See all 2,348 cited byDownload CSV of cited by

Genes113

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ALK238PubTator's text mininghttps://conductscience.org/library/genes/238NCBI Gene
ANXA1301PubTator's text mininghttps://conductscience.org/library/genes/301NCBI Gene
ATM472PubTator's text mininghttps://conductscience.org/library/genes/472NCBI Gene
B2M567PubTator's text mininghttps://conductscience.org/library/genes/567NCBI Gene
BCL2596PubTator's text mininghttps://conductscience.org/library/genes/596NCBI Gene
BCL6604PubTator's text mininghttps://conductscience.org/library/genes/604NCBI Gene
BCR613PubTator's text mininghttps://conductscience.org/library/genes/613NCBI Gene
BRAF673PubTator's text mininghttps://conductscience.org/library/genes/673NCBI Gene
BTK695PubTator's text mininghttps://conductscience.org/library/genes/695NCBI Gene
CCND1595PubTator's text mininghttps://conductscience.org/library/genes/595NCBI Gene
CCND2894PubTator's text mininghttps://conductscience.org/library/genes/894NCBI Gene
CCND3896PubTator's text mininghttps://conductscience.org/library/genes/896NCBI Gene
CCNE1898PubTator's text mininghttps://conductscience.org/library/genes/898NCBI Gene
CD1804064PubTator's text mininghttps://conductscience.org/library/genes/4064NCBI Gene
CD19930PubTator's text mininghttps://conductscience.org/library/genes/930NCBI Gene
CD2004345PubTator's text mininghttps://conductscience.org/library/genes/4345NCBI Gene
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD5921PubTator's text mininghttps://conductscience.org/library/genes/921NCBI Gene
CD79B974PubTator's text mininghttps://conductscience.org/library/genes/974NCBI Gene

See all 113 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35732829

GET https://conductscience.org/api/papers/v1/35732829/authors?page=2